Norges Bank
DYN icon

Norges Bank’s Dyne Therapeutics DYN Stock Holding History

Norges Bank’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
+49,319
New +$917K ﹤0.01% 1573
2026
Q1 		– Sell
-49,319
Closed -$965K – 423
2025
Q4 		$965K Buy
+49,319
New +$934K ﹤0.01% 1518
2025
Q3 		– Sell
-49,319
Closed -$470K – 475
2025
Q2 		$470K Sell
49,319
-60,603
-55% -$667K ﹤0.01% 1634
2025
Q1 		$1.15M Sell
109,922
-840,182
-88% -$12M ﹤0.01% 1605
2024
Q4 		$22.4M Buy
950,104
+517,777
+120% +$15.3M ﹤0.01% 1214
2024
Q3 		$15.5M Buy
432,327
+325,238
+304% +$12.9M ﹤0.01% 1271
2024
Q2 		$3.78M Buy
107,089
+59,831
+127% +$1.74M ﹤0.01% 1616
2024
Q1 		$1.34M Buy
+47,258
New +$1.07M ﹤0.01% 1773
2023
Q3 		– Sell
-195,600
Closed -$2.2M – 1986
2023
Q2 		$2.2M Sell
195,600
-168,000
-46% -$1.98M ﹤0.01% 1862
2023
Q1 		$4.19M Buy
363,600
+205,848
+130% +$2.67M ﹤0.01% 1804
2022
Q4 		$1.83M Buy
+157,752
New +$1.83M ﹤0.01% 1983
2022
Q2 		– Sell
-600,000
Closed -$5.78M – 2089
2022
Q1 		$5.78M Sell
600,000
-103,400
-15% -$880K ﹤0.01% 1843
2021
Q4 		$8.36M Sell
703,400
-13,700
-2% -$193K ﹤0.01% 1810
2021
Q3 		$11.6M Buy
717,100
+117,100
+20% +$2.08M ﹤0.01% 1716
2021
Q2 		$12.6M Hold
600,000
– – ﹤0.01% 1714
2021
Q1 		$9.32M Buy
600,000
+200,000
+50% +$3.87M ﹤0.01% 1802
2020
Q4 		$8.4M Sell
400,000
-80,769
-17% -$1.6M ﹤0.01% 1801
2020
Q3 		$9.71M Buy
+480,769
New +$10.6M ﹤0.01% 1717

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank's DYN Position: Q2 2026 in Review

Norges Bank opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 49,319 shares worth $1.1M. The stake represents ﹤0.01% of the portfolio and ranks #1573 among its holdings. This is a return to the name: Norges Bank previously reported a position in DYN as recently as Q4 2025.

Norges Bank first reported a position in DYN in Q3 2020 and has held it in 18 quarters since. The position peaked at $22.4M in Q4 2024. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Norges Bank held 49,319 shares of Dyne Therapeutics worth $1.1M as of Q2 2026.
  • Dyne Therapeutics was a new Norges Bank position in Q2 2026.
  • Dyne Therapeutics made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1573 holding.
  • Norges Bank first reported a position in Dyne Therapeutics in Q3 2020 and has held it in 18 quarters since.
  • Norges Bank's Dyne Therapeutics position peaked at $22.4M in Q4 2024.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.